Sarah Dewitt
Stock Analyst at JP Morgan
(2.97)
# 1,359
Out of 4,765 analysts
13
Total ratings
77.78%
Success rate
25.28%
Average return
Main Sectors:
Stocks Rated by Sarah Dewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GSHD Goosehead Insurance | Downgrades: Neutral | $100 → $135 | $111.60 | +20.97% | 2 | Jul 1, 2021 | |
| RNR RenaissanceRe Holdings | Assumes: Underweight | $173 | $236.23 | -26.77% | 4 | Nov 12, 2019 | |
| ALL The Allstate Corporation | Reiterates: Overweight | $120 | $202.00 | -40.59% | 1 | May 2, 2018 | |
| CB Chubb | Upgrades: Overweight | n/a | $288.55 | - | 1 | Nov 8, 2017 | |
| BRK.B Berkshire Hathaway | Initiates: Overweight | $210 | $504.36 | -58.36% | 1 | Sep 14, 2017 | |
| AWH Aspira Women's Health | Downgrades: Neutral | n/a | $0.15 | - | 4 | Jan 6, 2017 |
Goosehead Insurance
Jul 1, 2021
Downgrades: Neutral
Price Target: $100 → $135
Current: $111.60
Upside: +20.97%
RenaissanceRe Holdings
Nov 12, 2019
Assumes: Underweight
Price Target: $173
Current: $236.23
Upside: -26.77%
The Allstate Corporation
May 2, 2018
Reiterates: Overweight
Price Target: $120
Current: $202.00
Upside: -40.59%
Chubb
Nov 8, 2017
Upgrades: Overweight
Price Target: n/a
Current: $288.55
Upside: -
Berkshire Hathaway
Sep 14, 2017
Initiates: Overweight
Price Target: $210
Current: $504.36
Upside: -58.36%
Aspira Women's Health
Jan 6, 2017
Downgrades: Neutral
Price Target: n/a
Current: $0.15
Upside: -